Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SWI5-dependent HO expression protein 2 (She2p) is a non-canonical RNA-binding protein from the budding yeast Saccharomyces cerevisiae that is fundamental to the study of intracellular mRNA transport [1, 6]. It acts as a central component of the 'locasome,' a ribonucleoprotein complex responsible for the asymmetric localization of mRNAs, most notably ASH1 mRNA, to the bud tip of dividing yeast cells [1, 2, 4]. She2p functions as a tetramer that recognizes specific 'zipcode' stem-loop structures in the 3' untranslated region of target mRNAs and recruits the Myo4p–She3p motor-adaptor complex for transport along actin filaments [6, 16, 17]. This protein is an essential model for understanding how cells spatially regulate gene expression, though it has no known human ortholog and is not a recognized therapeutic target in clinical medicine [1, 3, 12]. While some research suggests that disrupting fungal mRNA transport systems could represent a novel strategy for antifungal development, She2p specifically is absent in major human pathogens like Candida albicans, which utilize different adaptor proteins for similar processes [12]. In a pharmaceutical or biotech context, 'She2 protein' is frequently an incorrect reference, often resulting from a typo for established human targets such as SHP2 (PTPN11) or HER2 (ERBB2), or an error in parsing scientific citations where 'She' is an author name and '2' refers to an institutional affiliation [10, 13].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SWI5-dependent HO expression protein 2 (She2p).